P2RX7 signaling restrains ILC1-mediated antitumor immunity (#249)

8:00 PM

Yuelin Zhao

Poster Session Two

ASB2 supports liver ILC1 maintenance and tumorcidal activities through balancing lipid metabolism (#173)

2:45 PM

Boqun Bao

Lightning Session One

HIF2α deficiency improves NK cell antitumor activities in the hypoxia tumor microenvironment (#245)

8:00 PM

Jinjin Wang

Poster Session Two

CD200R blockade enhances anti-tumor immunity by unleashing NK and CD8⁺ T cells in tumor (#248)

8:00 PM

zhengfeng Zhang

Poster Session Two

ATF3 Restrains ILC1 Potency in Ameliorating CD8⁺ T Cell-Mediated Viral Hepatitis (#235)

8:00 PM

Ying Tang

Poster Session Two

Deciphering the origin and development of tissue-resident ILCs from fetal to adult life (#210)

8:00 PM

HUI PENG

Poster Session Two